Deficiency in CYP7A1 in humans leads to significant metabolic aberrations, including impaired conversion of cholesterol to BAs, accumulation of hepatic cholesterol, reduction of LDL receptor expression, exacerbated hypercholesterolemia, and diminished statin response. The gene discussed is LDLR; the disease is Hypercholesterolemia.